![Cynthia L. Sundell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Cynthia L.
Sundell worked as the Vice President of Pharmacology at AtheroGenics, Inc. from 1995 to 2009.
She also worked as the Vice President of Drug Development at ABIONYX Pharma SA.
Precedenti posizioni note di Cynthia L. Sundell
| Società | Posizione | Fine |
|---|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | 14/07/2009 |
| ABIONYX PHARMA SA | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
27
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
